These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23321217)

  • 1. VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.
    Schlingemann RO; Van Noorden CJ; Diekman MJ; Tiller A; Meijers JC; Koolwijk P; Wiersinga WM
    Diabetes Care; 2013 Jun; 36(6):1629-34. PubMed ID: 23321217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker.
    Niers TM; Richel DJ; Meijers JC; Schlingemann RO
    PLoS One; 2011; 6(5):e19873. PubMed ID: 21637343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
    Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
    Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.
    Singh K; Sandler S; Espes D
    J Diabetes Res; 2017; 2017():6192896. PubMed ID: 28421206
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
    Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
    Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.
    Kakizawa H; Itoh M; Itoh Y; Imamura S; Ishiwata Y; Matsumoto T; Yamamoto K; Kato T; Ono Y; Nagata M; Hayakawa N; Suzuki A; Goto Y; Oda N
    Metabolism; 2004 May; 53(5):550-5. PubMed ID: 15131756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects.
    Esteghamati A; Arefzadeh A; Zandieh A; Salehi Sadaghiani M; Noshad S; Nakhjavani M
    J Endocrinol Invest; 2013; 36(7):474-7. PubMed ID: 23877020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.
    Zhang Q; Fang W; Ma L; Wang ZD; Yang YM; Lu YQ
    Medicine (Baltimore); 2018 Apr; 97(15):e0415. PubMed ID: 29642210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes.
    Ashraf A; Mick G; Meleth S; Abdullatif H; Wang X; McCormick K
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4920-3. PubMed ID: 15914522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers.
    Brouwers J; Noviyanti R; Fijnheer R; de Groot PG; Trianty L; Mudaliana S; Roest M; Syafruddin D; van der Ven A; de Mast Q
    PLoS One; 2014; 8(6):e64850. PubMed ID: 23755151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P; Tarnow L; Oestergaard PB; Parving HH
    Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    Bonnefond A; Saulnier PJ; Stathopoulou MG; Grarup N; Ndiaye NC; Roussel R; Nezhad MA; Dechaume A; Lantieri O; Hercberg S; Lauritzen T; Balkau B; El-Sayed Moustafa JS; Hansen T; Pedersen O; Froguel P; Charpentier G; Marre M; Hadjadj S; Visvikis-Siest S
    PLoS One; 2013; 8(2):e55921. PubMed ID: 23405237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
    Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
    Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy.
    Shimada K; Baba T; Neugebauer S; Onozaki A; Yamada D; Midorikawa S; Sato W; Watanabe T
    J Diabetes Complications; 2002; 16(6):386-90. PubMed ID: 12477622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.
    Zorena K; Myśliwska J; Myśliwiec M; Rybarczyk-Kapturska K; Malinowska E; Wiśniewski P; Raczyńska K
    J Hum Hypertens; 2010 Nov; 24(11):755-62. PubMed ID: 20164848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes.
    Aoki I; Shimoyama K; Aoki N; Homori M; Yanagisawa A; Nakahara K; Kawai Y; Kitamura SI; Ishikawa K
    J Am Coll Cardiol; 1996 Mar; 27(3):560-6. PubMed ID: 8606265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with Type 2 diabetes and hypertension.
    Cipriani R; Sensi M; Gabriele A; Gatti A; Mandosi E; Di Mario U; Morano S
    Diabetes Nutr Metab; 2004 Apr; 17(2):90-4. PubMed ID: 15244100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The assessment of the correlation between vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF-alpha), interleukin 6 (IL-6), glycaemic control (HbA1c) and the development of the diabetic retinopathy in children with diabetes mellitus type 1].
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
    Klin Oczna; 2007; 109(4-6):150-4. PubMed ID: 17725274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.